The application of nanoparticles in gene therapy and magnetic resonance imaging

Microscopy Research and Technique

Volumn 74, Issue 7, 2011, Pages 577-591

  Herranz, Fernando ^a,b   Almarza, Elena ^c   Rodríguez, Ignacio ^a   Salinas, Beatriz ^a,b   Rosell, Yamilka ^a   Desco, Manuel ^b,d   Bulte, Jeff W ^e   Ruiz Cabello, Jesús ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioimaging; Gene therapy; Iron oxide; Nanoparticles; Theranostic

Indexed keywords

DISEASE CONTROL; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; NANOMAGNETICS; NANOPARTICLES; SYNTHESIS (CHEMICAL);

BIO-IMAGING; GENE TRANSDUCTION; GENETIC INFORMATION; IMAGING CONTRAST; IN-VIVO; SYNERGIC EFFECTS; THERANOSTICS; THERAPY STRATEGIES; VIVO APPLICATIONS;

GENE THERAPY;

EID: 79959528672     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.20992     Document Type: Review

References (102)

1. Airenne KJ, Hiltunen MO, Turunen MP, Turunen AM, Laitinen OH, Kulomaa MS, Ylä-Herttuala S. 2000. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther 7: 1499-1504.
2. Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, Morecki S, Andolfi G, Tabucchi A, Carlucci F, Marinello E, Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo MG, Bordignon C. 2002a. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296: 2410-2413.
3. Aiuti A, Vai S, Mortellaro A, Casorati G, Ficara F, Andolfi G, Ferrari G, Tabucchi A, Carlucci F, Ochs HD, Notarangelo LD, Roncarolo MG, Bordignon C. 2002b. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nat Med 8: 423-425.
4. Allen M, Bulte JWM, Liepold L, Basu G, Zywicke HA, Frank JA, Young M, Douglas T. 2005. Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magnetic resonance in medicine: Official journal of the society of magnetic resonance in medicine. Soc Magn Reson Med 54: 807-812.
5. Baum C, Kustikova O, Modlich U, Li Z, Fehse B. 2006. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 17: 253-263.
6. Bhattarai SR, Kim SY, Jang KY, Lee KC, Yi HK, Lee DY, Kim HY, Hwang PH. 2008. Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line. J Virol Meth 2005-2008.
7. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF. 1995. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 270: 475-480.
8. Boote E, Fent G, Kattumuri V, Casteel S, Katti K, Chanda N, Kannan R, Katti K, Churchill R. 2010. Gold nanoparticle contrast in a phantom and juvenile swine: Models for molecular imaging of human organs using x-ray computed tomography. Acad Radiol 17: 410-417.
9. Bryson JM, Fichter KM, Chu W-J, Lee J-H, Li J, Madsen LA, McLendon PM, Reineke TM. 2009. Polymer beacons for luminescence and magnetic resonance imaging of DNA delivery. October 106: 1-6.
10. Cai QY, Kim SH, Choi KS, Kim SY, Byun SJ, Kim KW, Park SH, Juhng SK, Yoon KH. 2007. Colloidal gold nanoparticles as a blood-pool contrast agent for x-ray computed tomography in mice. Invest Radiol 42: 797-806.
11. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A. 2000. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672.
12. Chan L, Nesbeth D, Mackey T, Galea-Lauri J, Gäken J, Martin F, Collins M, Mufti G, Farzaneh F, Darling D. 2005. Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells. J Virology 79: 13190-13194.
13. Chen C-C, Lin Y-P, Wang C-W, Tzeng H-C, Wu C-H, Chen Y-C, Chen C-P, Chen L-C, Wu Y-C. 2006. DNA-gold nanorod conjugates for remote control of localized gene expression by near infrared irradiation. J Am Chem Soc 128: 3709-3715.
14. Cheon J, Lee JH. 2008. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res 41: 1630-1640.
15. Cherukuri P, Glazer ES, Curley SA. 2010. Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev 62: 339-345.
16. Cho SJ, Jarrett BR, Louie AY, Kauzlarich SM. 2006. Gold-coated iron nanoparticles: a novel magnetic resonance agent for T-1 and T-2 weighted imaging. Nanotechnology 17: 640-644.
17. Cho W-S, Kim S, Han BS, Son WC, Jeong J. 2009. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. Toxicol Lett 191: 96-102.
18. Chorny M, Fishbein I, Alferiev I, Levy RJ. 2009. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. Mol Pharm 6: 1380-1387.
19. Conde J, de La Fuente JM, Baptista PV. 2010. RNA quantification using gold nanoprobes-Application to cancer diagnostics. J Nanobiotechnol 8: 5.
20. Cormode DP, Jarzyna PA, Mulder WJM, Fayad ZA. 2010. Modified natural nanoparticles as contrast agents for medical imaging. Adv Drug Deliv Rev 62: 329-338.
21. Culver K, Cornetta K, Morgan R, Morecki S, Aebersold P, Kasid A, Lotze M, Rosenberg SA, Anderson WF, Blaese RM. 1991. Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci USA 88: 3155-3159.
22. De Palma M, Montini E, Santoni De Sio FR, Benedicenti F, Gentile A, Medico E, Naldini L. 2005. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood 105: 2307-2315.
23. Dilnawaz F, Singh A, Mohanty C, Sahoo SK. 2010. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 31: 3694-3706.
24. Dong BH, Cao LX, Su G, Liu W, Qu H, Zhai H. 2010. Water-soluble ZnS:Mn/ZnS core/shell nanoparticles prepared by a novel two-step method. J Alloys Compounds 492: 363-367.
25. Doshi N, Mitragotri S. 2009. Designer biomaterials for nanomedicine. Adv Funct Mater 19: 3843-3854.
26. Everts M, Saini V, Leddon JL, Kok RJ, Stoff-Khalili M, Preuss Ma, Millican CL, Perkins G, Brown JM, Bagaria H, Nikles DE, Johnson DT, Zharov VP, Curiel DT. 2006. Covalently linked Au nanoparticles to a viral vector: Potential for combined photothermal and gene cancer therapy. Nano Lett 6: 587-591.
27. Gao JH, Gu HW, Xu B. 2009. Multifunctional magnetic nanoparticles: Design, synthesis, and biomedical applications. Acc Chem Res 42: 1097-1107.
28. Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J, Brouns G, Schmidt M, Von Kalle C, Barington T, Jakobsen MA, Christensen HO, Al Ghonaium A, White HN, Smith JL, Levinsky RJ, Ali RR, Kinnon C, Thrasher AJ. 2004. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364: 2181-2187.
29. Ghosh PS, Kim C-K, Han G, Forbes NS, Rotello VM. 2008. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano 2: 2213-2218.
30. Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA. 2009. Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 131: 2072-2073.
31. Gould P. 2004. Nanoparticles probe biosystems. Mater Today 7: 36-43.
32. Haacke EM, Thompson MR, Venkatesan R. 1999. Magnetic resonance imaging: Physical principles and sequence design. New York: J Wiley and Sons.
33. Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay J-P, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M. 2002. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346: 1185-1193.
34. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval J-L, Fraser CC, Cavazzana-Calvo M, Fischer A. 2003. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348: 255-256.
35. Haim H, Steiner I, Panet A. 2005. Synchronized infection of cell cultures by magnetically controlled virus. Society 79: 622-625.
36. Han G, You C-C, Kim B-J, Turingan RS, Forbes NS, Martin CT, Rotello VM. 2006. Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles. Angew Chem 118: 3237-3241.
37. Herranz F, Morales MP, Roca AG, Desco M, Ruiz-Cabello J. 2008a. A new method for the rapid synthesis of water stable superparamagnetic nanoparticles. Chem Eur J 14: 9126-9130.
38. Herranz F, Morales MP, Roca AG, Vilar R, Ruiz-Cabello J. 2008b. A new method for the aqueous functionalization of superparamagnetic Fe2O3 nanoparticles. Contrast Media Molecular Imaging 3: 215-222.
39. Hofmann A, Wenzel D, Becher UM, Freitag DF, Klein AM, Eberbeck D, Schulte M, Zimmermann K, Bergemann C, Gleich B, Roell W, Weyh T, Trahms L, Nickenig G, Fleischmann BK, Pfeifer A. 2008. Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Direct.
40. Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H, Brugman MH, Pike-Overzet K, Chatters SJ, de Ridder D, Gilmour KC, Adams S, Thornhill SI, Parsley KL, Staal FJT, Gale RE, Linch DC, Bayford J, Brown L, Quaye M, Kinnon C, Ancliff P, Webb DK, Schmidt M, von Kalle C, Gaspar HB, Thrasher AJ. 2008. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118: 3143-3150.
41. Hughes C, Galea-lauri J, Farzaneh F, Darling D. 2001. Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors. Mol Ther 3: 623-630.
42. Huh Y-M, Lee E-S, Lee J-H, Jun Y-W, Kim P-H, Yun C-O, Kim J-H, Suh J-S, Cheon J. 2007. Hybrid nanoparticles for magnetic resonance imaging of target-specific viral gene delivery. Adv Mater 19: 3109-3112.
43. Jiles D. 1998. Introduction to Magnetism and Magnetic Materials. CRC Press LLC 1998. ISBN: 0412798603.
44. Jin S, Ye K. 2007. Nanoparticle-mediated drug delivery and gene therapy. Biomed Eng 32-41.
45. Jin YH, Li AZ, Hazelton SG, Liang S, John CL, Selid PD, Pierce DT, Zhao JX. 2009. Amorphous silica nanohybrids: Synthesis, properties and applications. Coord Chem Rev 253: 2998-3014.
46. Jung LS, Campbell CT, Chinowsky TM, Mar MN, Yee SS. 1998. Quantitative interpretation of the response of surface plasmon resonance sensors to adsorbed films. Langmuir 14: 5636-5648.
47. Kaikkonen MU, Lesch HP, Pikkarainen J, Räty JK, Vuorio T, Huhtala T, Taavitsainen M, Laitinen T, Tuunanen P, Gröhn O, Närvänen A, Airenne KJ, Ylä-Herttuala S. 2009. (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery. Gene Ther 16: 894-904.
48. Kamau SW, Hassa PO, Steitz B, Petri-fink A, Hofmann H, Hofmann-Amtenbrink M, Hottiger MO. 2006. Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acids Res 34: e40.
49. Kamei K, Mukai Y, Kojima H, Yoshikawa T, Yoshikawa M, Kiyohara G, Yamamoto TA, Yoshioka Y, Okada N, Seino S, Nakagawa S. 2009. Direct cell entry of gold/iron-oxide magnetic nanoparticles in adenovirus mediated gene delivery. Biomaterials 30: 1809-1814.
50. Kim D, Park S, Lee JH, Jeong YY, Jon S. 2007. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo x-ray computed tomography imaging. J Am Chem Soc 129: 7661-7665.
51. Kim J, Park S, Lee JE, Jin SM, Lee JH, Lee IS, Yang I, Kim J-S, Kim SK, Cho M-H, Hyeon T. 2006. Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem Int Ed 45: 7754-7758.
52. Kovesdi I, Brough DE, Bruder JT, Wickham TJ. 1997. Adenoviral vectors for gene transfer. Curr Opin Biotechnol 8: 583-589.
53. Kurihara K, Suzuki K. 2002. Theoretical understanding of an absorption-based surface plasmon resonance sensor based on Kretchmann's theory. Anal Chem 74: 696-701.
54. Lee J-H, Huh Y-M, Jun Y-W, Seo J-W, Jang J-T, Song H-T, Kim S, Cho E-J, Yoon H-G, Suh J-S, Cheon J. 2007. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 13: 95-99.
55. Leopold PL, Crystal RG. 2007. Intracellular trafficking of adenovirus: Many means to many ends. Adv Drug Deliv Rev 59: 810-821.
56. Lesch HP, Pikkarainen JT, Kaikkonen MU, Taavitsainen M, Samaranayake H, Lehtolainen-Dalkilic P, Vuorio T, Määttä A-M, Wirth T, Airenne KJ, Ylä-Herttuala S. 2009. Avidin fusion protein-expressing lentiviral vector for targeted drug delivery. Hum Gene Ther 20: 871-882.
57. Lesch HP, Kaikkonen MU, Pikkarainen JT, Ylä-Herttuala S. 2010. Avidin-biotin technology in targeted therapy. Exp Opin Drug Deliv 7: 551-564.
58. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. 2000. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18: 410-414.
59. Liu BJ, Li XY, Chen W, Liu RX, Ge GL. 2009. Surface ligand exchange and phase transfer of iron oxide magnetic nanoparticles. Acta Physico-Chimica Sinica 26: 784-788.
60. Lowe MP. 2004. Activated MR contrast agents. Curr Pharm Biotechnol 5: 519-528.
61. Mallidi S, Larson T, Aaron J, Sokolov K, Emelianov S. 2007. Molecular specific optoacoustic imaging with plasmonic nanoparticles. Opt Exp 15: 6583-6588.
62. McCarthy JR, Weissleder R. 2008. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 60: 1241-1251.
63. Morishita N, Nakagami H, Morishita R, Takeda S, Mishima F, Terazono B, Nishijima S, Kaneda Y, Tanaka N. 2005. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Commun 334: 1121-1126.
64. Mulder WJM, Strijkers GJ, Van Tilborg GAF, Cormode DP, Fayad ZA, Nicolay K. 2009. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res 42: 904-914.
65. Nune SK, Gunda P, Thallapally PK, Lin YY, Forrest ML, Berkland CJ. 2009. Nanoparticles for biomedical imaging. Exp Opin Drug Deliv 6: 1175-1194.
66. Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kühlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Lüthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M. 2006. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12: 401-409.
67. Park JA, Reddy PAN, Kim HK, Kim IS, Kim GC, Chang Y, Kim TJ. 2008. Gold nanoparticles functionalised by Gd-complex of DTPA-bis(amide) conjugate of glutathione as an MRI contrast agent. Bioorg Med Chem Lett 18: 6135-6137.
68. Park JA, Kim HK, Kim JH, Jeong SW, Jung JC, Lee GH, Lee J, Chang Y, Kim TJ. 2010. Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent. Bioorg Med Chem Lett 20: 2287-2291.
69. Plank C, Scherer F, Schillinger U, Bergemann C, Anton M. 2003a. Magnetofection: Enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields. J Liposome Res 13: 29-32.
70. Plank C, Schillinger U, Bergemann C, Anton M, Rosenecker J. 2003b. The magnetofection method: Using magnetic force to enhance gene delivery. New York 384: 737-747.
71. Popovtzer R, Agrawal A, Kotov NA, Popovtzer A, Balter J, Carey TE, Kopelman R. 2008. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett 8: 4593-4596.
72. Portney NG, Singh K, Chaudhary S, Destito G, Schneemann A, Manchester M, Ozkan M. 2005. Organic and inorganic nanoparticle hybrids. Langmuir: ACS J Surf Colloids 21: 2098-2103.
73. Räty JK, Airenne KJ, Marttila AT, Marjomäki V, Hytönen VP, Lehtolainen P, Laitinen OH, Mähönen AJ, Kulomaa MS, Ylä-Herttuala S. 2004. Enhanced gene delivery by avidin-displaying baculovirus. Mol Ther: J Am Soc Gene Ther 9: 282-291.
74. Räty JK, Liimatainen T, Wirth T, Airenne KJ, Ihalainen TO, Huhtala T, Hamerlynck E, Vihinen-Ranta M, Närvänen A, Ylä-Herttuala S, Hakumäki JM. 2006. Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Ther 1440-1446.
75. Rharny M, Fishbein I, Alferiev I. 2009. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. Mol Pharm.
76. Rhim W-K, Kim J-S, Nam J-M. 2008. Lipid-gold-nanoparticle hybrid-based gene delivery. Small 4: 1651-1655.
77. Roca AG, Morales MP, O'Grady K, Serna CJ. 2006a. Structural and magnetic properties of uniform magnetite nanoparticles prepared by high temperature decomposition of organic precursors. Nanotechnology 17: 2783-2788.
78. Roca AG, Morales MP, Serna CJ. 2006b. Synthesis of monodispersed magnetite particles from different organometallic precursors. IEEE Trans Magn 42: 3025-3029.
79. Rodriguez I, Perez-Rial S, Gonzalez-Jimenez J, Perez-Sanchez JM, Herranz F, Beckmann N, Ruiz-Cabello J. 2008. Magnetic resonance methods and applications in pharmaceutical research. J Pharm Res 13: 225-240.
80. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL. 1990. Gene transfer into humans-Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323: 570-578.
81. Saha A, Basiruddin SK, Pradhan N, Jana NR. 2010. Ligand exchange approach in deriving magnetic-fluorescent and magnetic-plasmonic hybrid nanoparticle. Langmuir 26: 4351-4356.
82. Seale-Goldsmith M-M, Leary JF. 2009. Nanobiosystems. Wiley interdisciplinary reviews. Nanomed Nanobiotechnol 1: 553-567.
83. Seino S, Kusunose T, Sekino T, Kinoshita T, Nakagawa T, Kakimi Y, Kawabe Y, Iida J, Yamamoto TA, Mizukoshi Y. 2006. Synthesis of gold/magnetic iron oxide composite nanoparticles for biomedical applications with good dispersibility. J Appl Phys 99.
84. Shevchenko EV, Bodnarchuk MI, Kovalenko MV, Talapin DV, Smith RK, Aloni S, Heiss W, Alivisatos AP. 2008. Gold/Iron oxide core/hollow-shell nanoparticles. Adv Mater 20: 4323-4329.
85. Shin S, Shea LD. 2010. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol Ther: J Am Soc Gene Ther 18: 700-706.
86. Shubayev VI, Pisanic TR, Jin S. 2009. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61: 467-477.
87. Sperling RA, Rivera Gil P, Zhang F, Zanella M, Parak WJ. 2008. Biological applications of gold nanoparticles. Chem Soc Rev 37: 1896-1908.
88. Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, Kinner A, Schmidt M, Krämer A, Schwäble J, Glimm H, Koehl U, Preiss C, Ball C, Martin H, Göhring G, Schwarzwaelder K, Hofmann W-K, Karakaya K, Tchatchou S, Yang R, Reinecke P, Kühlcke K, Schlegelberger B, Thrasher AJ, Hoelzer D, Seger R, von Kalle C, Grez M. 2010. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16: 198-204.
89. Strijkers GJ, Mulder WJ, van Tilborg GA, Nicolay K. 2007. MRI contrast agents: Current status and future perspectives. Anticancer Agents Med Chem 7: 291-305.
90. Sun S, Zeng H, Robinson DB, Raoux S, Rice PM, Wang SX, Li G. 2004. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 126: 273-279.
91. Takahashi H, Niidome Y, Yamada S. 2005. Controlled release of plasmid DNA from gold nanorods induced by pulsed near-infrared light. Chem Commun (Cambridge, England): 2247-2249.
92. Valois CRA, Braz JM, Nunes ES, Vinolo MAR, Lima ECD, Curi R, Kuebler WM, Azevedo RB. 2010. The effect of DMSA-functionalized magnetic nanoparticles on transendothelial migration of monocytes in the murine lung via a beta(2) integrin-dependent pathway. Biomaterials 31.
93. Veiseh O, Gunn JW, Zhang M. 2010. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 62: 284-304.
94. Warsi MF, Adams RW, Duckett SB, Chechik V. 2010. Gd-functionalised Au nanoparticles as targeted contrast agents in MRI: Relaxivity enhancement by polyelectrolyte coating. Chem Commun (Camb) 46: 451-453.
95. Weber W, Lienhart C, Daoud-El Baba M, Grass RN, Kohler T, Müller R, Stark WJ, Fussenegger M. 2009. Magnet-guided transduction of mammalian cells and mice using engineered magnetic lentiviral particles. J Biotech 141: 118-122.
96. Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, Muldoon LL, Neuwelt EA. 2009. Superparamagnetic iron oxide nanoparticles: Diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cerebr Blood Flow Metab 30: 15-35.
97. Wijaya A, Schaffer SB, Pallares IG, Hamad-Schifferli K. 2009. Selective release of multiple DNA oligonucleotides from gold nanorods. ACS Nano 3: 80-86.
98. Wilson R. 2008. The use of gold nanoparticles in diagnostics and detection. Chem Soc Rev 37: 2028-2045.
99. 4@Au nanoparticles with magnetic recyclable catalytic properties. Mater Res Bull 45: 513-517.
100. 3 decorated by Au nanoparticles and their enhanced sensor performance. Nanotechnology 095501 (8pp).
101. Xiao M, Nyagilo J, Arora V, Kulkarni P, Xu D, Sun X, Dave DP. 2010. Gold nanotags for combined multi-colored Raman spectroscopy and x-ray computed tomography. Nanotechnology 21: 035101.
102. 4@Au nanoparticles with magnetic recyclable catalytic properties. Mater Res Bull 513-517.